Today, medical leaders are participating in an industry dominated by the production of science and technology. But what is scientifically possible for the body and what is humane for the person are different questions which medicine must answer together.
A few months ago, kidney specialist Dr. Stanley Goldfarb was fired from UpToDate, a digital research tool for physicians. Last year, the president of the University of Pennsylvania Perelman School of Medicine, where Dr. Goldfarb served as an associate dean, wrote a public letter accusing him of racism while students and colleagues circulated a petition calling for his title as professor emeritus to be stripped.
Dr. Goldfarb’s purported crimes had nothing to do with medicine and everything to do with his public opposition to DEI (“Diversity, Equity, and Inclusion”) in medicine.
The poll, conducted by Summit Ministries in conjunction with McLaughlin & Associates, was released on Monday and centered on voter-sentiment on LGBT issues.
Robyn Strader, a former nurse practitioner, filed a charge of discrimination this month against CVS, alleging the company violated Title VII of the Civil Rights Act, which prohibits discrimination based on religion.
A prominent theologian and a well-known bioethicist say they see no ethical problems with the world’s first successful pig-to-human heart transplant – and they both believe the field holds much promise for the future of medical science.
Donald McNeil is the New York Times science and health reporter focusing on plagues. McNeil has reported that “non-pharmaceutical interventions” such as mask-wearing and social distancing have “made a huge difference in lives saved.” Now he focuses on pharmaceutical interventions such as vaccines and monoclonal antibodies. On this front, he has become “cautiously optimistic,” citing experts who “are saying, with genuine confidence, that the pandemic in the United States will be over far sooner than they expected, possibly by the middle of next year.”
